arrow
D

Donald P. Tashkin

University of California System
H指数:107
被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combining Pirfenidone With Mycophenolate Mofetil for Systemic Sclerosis–Related Interstitial Lung Disease (Scleroderma Lung Study III): An Investigator-Initiated, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

联合使用吡非尼酮与霉酚酸酯治疗系统性硬化症相关性间质性肺疾病(硬皮病肺研究III):一项研究者发起的、多中心、随机、双盲、安慰剂对照的2期临床试验

2025-11-260
OAAI
Air pollution, lung function, and respiratory symptoms in the MACS and WIHS
2024-10-300
PRE
Lung Cancer Burden in the SPIROMICS Cohort.
2024-10-300
PRE
Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium

COPD基金会雾化器联盟关于减轻雾化过程中传播呼吸道感染风险的指南

CHEST
IF8.6
2024-03-014
OAAI
Late Breaking Abstract - Lung volumes differentiate emphysema- vs. airway diseasedominant pathologies with distinct clinical features in tobacco-exposed persons with preserved spirometry in SPIROMICS
2023-10-270
PRE
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
2023-08-019
PRE
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort
CHEST
IF8.6
2023-03-013
OAAI
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD
CHEST
IF8.6
2023-03-016
OAAI